Company: INTS
Filing Date: 2025-04-25
Form Type: 424B4
Source: 0001628280-25-020056
Chunk: 5

Company: INTENSITY THERAPEUTICS, INC.
Filing Date: 2025-04-25
Form: 424B4
Chunk 5
---
 same may be amended, supplemented or superseded by the risks and uncertainties described under similar headings in the other documents that are filed after the date hereof and incorporated by reference into this prospectus, regarding, among other things:

• the initiation, timing, progress and results of future preclinical studies and clinical trials, and our research and development programs;

• our need to raise additional funding before we can expect to generate any revenues from product sales;

• our plans to develop and commercialize our product candidates;

• the timing or likelihood of regulatory filings and approvals;

• the ability of our research to generate and advance additional product candidates;

• the implementation of our business model, strategic plans for our business, product candidates and technology;

• our commercialization, marketing and manufacturing capabilities and strategy;

• the rate and degree of market acceptance and clinical utility of our system;

• our competitive position;

• our intellectual property position;

• developments and projections relating to our competitors and our industry;

• our ability to maintain and establish collaborations or obtain additional funding;

• our expectations related to the use of our cash and cash equivalents and investments;

• our estimates regarding expenses, future revenue, capital requirements and needs for additional financing; and

• other factors that may impact our financial results.

All of our forward-looking statements are as of the date of this prospectus only. In each case, actual results may differ materially from such forward-looking information. We can give no assurance that such expectations or

<div align='center'>1</div>

forward-looking statements will prove to be correct. An occurrence of or any material adverse change in one or more of the risk factors or risks and uncertainties referred to in this prospectus or included in our other public disclosures or our other periodic reports or other documents or filings filed with or furnished to the SEC, could materially and adversely affect our business, prospects, financial condition and results of operations. Except as required by law, we do not undertake or plan to update or revise any such forward-looking statements to reflect actual results, changes in plans, assumptions, estimates or projections or other circumstances affecting such forward-looking statements occurring after the date of this prospectus, even if such results, changes or circumstances make it clear that any forward-looking information will not be realized. Any public statements or disclosures by us following this prospectus that modify or impact any of the forward-looking statements contained herein will be deemed to modify or supersede such statements in this prospectus.

<div align='center'>2</div>

### PROSPECTUS SUMMARY
The following is a